There are 2949 resources available
Conclusions
Presenter: Nicoletta Colombo
Session: ESMO Colloquium supported by Eisai: Controversies endometrial cancer: Update on ESMO clinical practice guidelines (CPG) and future treatment direction
Resources:
Slides
Webcast
1088P - Efficacy of post-operative radiation therapy in non-metastatic Merkel cell carcinoma: A registry-based analysis
Presenter: Giuseppe Lamberti
Session: E-Poster Display
Resources:
Abstract
1089P - POD1UM-201: A phase II study of retifanlimab (INCMGA00012) in advanced or metastatic Merkel cell carcinoma (MCC)
Presenter: Giovanni Grignani
Session: E-Poster Display
Resources:
Abstract
1090P - Real-world (RW) clinical outcomes in patients (pts) with locally advanced (LA) or metastatic Merkel cell carcinoma (mMCC) treated in United States (US) oncology clinical practices: Results from SPEAR-Merkel
Presenter: Charles Cowey
Session: E-Poster Display
Resources:
Abstract
1092P - Non-progression with avelumab treatment in patients with metastatic Merkel cell carcinoma (mMCC) is associated with a clinically meaningful better health-related quality of life compared with progressive disease
Presenter: Murtuza Bharmal
Session: E-Poster Display
Resources:
Abstract
905P - Outcomes of fludarabine, melphalan and low dose total body irradiation as a reduced intensity regimen in allogeneic peripheral blood stem cell transplantation
Presenter: Dipenkumar Modi
Session: E-Poster Display
Resources:
Abstract
906P - Infectious complications in patients with acute graft-versus-host disease
Presenter: Aleksandr Siniaev
Session: E-Poster Display
Resources:
Abstract
907P - Invasive aspergillosis caused by aspergillus non-fumigatus in children and adults after hematopoietic stem cell transplantation (HSCT) & chemotherapy
Presenter: Yuliya Rogacheva
Session: E-Poster Display
Resources:
Abstract
908P - Impact of serum galactomannan assay on diagnosis and outcome of invasive fungal infections in high risk febrile neutropenia: A prospective cohort study
Presenter: VIRAJ NEVREKAR
Session: E-Poster Display
Resources:
Abstract
885TiP - LIO-1: A phase II study of lucitanib + nivolumab in patients (pts) with gynaecological tumours (CO-3810-101; NCT04042116; ENGOT-GYN3/AGO/LIO)
Presenter: Nicole Concin
Session: E-Poster Display
Resources:
Abstract